Form 4: Sotera Health Director Ann Klee Receives RSU Grant

Director Ann R. Klee was granted 14,970 restricted stock units as part of the Sotera Health Company 2020 Omnibus Incentive Plan.

Summary

• Director Ann R. Klee acquired 14,970 restricted stock units (RSUs) on May 22, 2026.
• Each RSU represents a right to receive one share of common stock upon vesting.
• The total beneficial ownership for the director following this transaction is 140,926 shares, including the new RSUs.
• The grant was issued under the Sotera Health Company 2020 Omnibus Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine regulatory disclosure regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard equity grant process consistent with corporate governance practices.

Negatives

• None identified; this is a routine disclosure of director compensation.

Risks

• Vesting is subject to the director's continued service through the earlier of the first anniversary of the grant or the next annual shareholders meeting.

Future Outlook

The RSUs are scheduled to vest in full on the earlier of the first anniversary of the grant date or the date immediately prior to the next regular annual shareholders meeting.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the healthcare services sector to ensure long-term alignment with corporate performance and shareholder value.

Comparison to Industry Standards

• The use of RSU grants for board compensation is consistent with standard practices for mid-cap healthcare companies.
• Vesting schedules tied to annual meetings are common governance structures for public company directors.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 14,970 RSUs on the earlier of May 22, 2027, or the date of the next annual shareholders meeting.

Key Dates

Keywords

Sotera Health, SHC, Form 4, Insider Trading, Director Compensation, Restricted Stock Units